FATE logo

Fate Therapeutics (FATE) Net Income

Annual Net Income

-$160.93 M
+$120.79 M+42.88%

December 31, 2023


Summary


Performance

FATE Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEprofitabilitymetrics:

Quarterly Net Income

-$47.68 M
-$9.25 M-24.07%

September 30, 2024


Summary


Performance

FATE Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEprofitabilitymetrics:

TTM Net Income

-$178.23 M
-$2.51 M-1.43%

September 30, 2024


Summary


Performance

FATE TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

FATE Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+42.9%-5.5%-2.9%
3 y3 years+7.2%-152.5%+24.1%
5 y5 years-141.6%-42.2%-59.3%

FATE Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+42.9%-152.5%+42.9%-10.8%+39.4%
5 y5-year-64.0%+42.9%-152.5%+42.9%-81.6%+39.4%
alltimeall time-1098.5%+42.9%-1243.8%+42.9%-4233.4%+39.4%

Fate Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$47.68 M(+24.1%)
-$178.23 M(+1.4%)
Jun 2024
-
-$38.43 M(-20.0%)
-$175.72 M(-7.5%)
Mar 2024
-
-$48.00 M(+8.8%)
-$190.05 M(+18.1%)
Dec 2023
-$160.93 M(-42.9%)
-$44.12 M(-2.3%)
-$160.93 M(-7.1%)
Sep 2023
-
-$45.17 M(-14.4%)
-$173.17 M(-18.1%)
Jun 2023
-
-$52.76 M(+179.4%)
-$211.56 M(-9.9%)
Mar 2023
-
-$18.88 M(-66.5%)
-$234.91 M(-16.6%)
Dec 2022
-$281.72 M(+32.8%)
-$56.36 M(-32.6%)
-$281.72 M(-4.2%)
Sep 2022
-
-$83.56 M(+9.8%)
-$293.98 M(+15.9%)
Jun 2022
-
-$76.11 M(+15.9%)
-$253.72 M(+9.0%)
Mar 2022
-
-$65.69 M(-4.3%)
-$232.75 M(+9.7%)
Dec 2021
-$212.15 M(+22.4%)
-$68.62 M(+58.4%)
-$212.15 M(+7.9%)
Sep 2021
-
-$43.31 M(-21.4%)
-$196.64 M(-7.3%)
Jun 2021
-
-$55.13 M(+22.3%)
-$212.02 M(+14.6%)
Mar 2021
-
-$45.09 M(-15.1%)
-$184.96 M(+6.7%)
Dec 2020
-$173.39 M(+76.7%)
-$53.11 M(-9.5%)
-$173.39 M(+16.7%)
Sep 2020
-
-$58.68 M(+109.0%)
-$148.58 M(+27.5%)
Jun 2020
-
-$28.07 M(-16.3%)
-$116.50 M(+4.1%)
Mar 2020
-
-$33.52 M(+18.4%)
-$111.91 M(+14.0%)
Dec 2019
-$98.15 M(+47.4%)
-$28.30 M(+6.4%)
-$98.15 M(+14.3%)
Sep 2019
-
-$26.61 M(+13.3%)
-$85.87 M(+12.9%)
Jun 2019
-
-$23.48 M(+18.8%)
-$76.05 M(+5.3%)
Mar 2019
-
-$19.76 M(+23.3%)
-$72.22 M(+8.4%)
Dec 2018
-$66.60 M
-$16.03 M(-4.5%)
-$66.60 M(+5.6%)
Sep 2018
-
-$16.78 M(-14.6%)
-$63.07 M(+10.7%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$19.65 M(+39.0%)
-$56.97 M(+21.3%)
Mar 2018
-
-$14.13 M(+13.1%)
-$46.96 M(+9.3%)
Dec 2017
-$42.95 M(+28.4%)
-$12.50 M(+17.0%)
-$42.95 M(+11.9%)
Sep 2017
-
-$10.68 M(+10.8%)
-$38.40 M(+5.3%)
Jun 2017
-
-$9.64 M(-4.8%)
-$36.45 M(+3.5%)
Mar 2017
-
-$10.13 M(+27.5%)
-$35.21 M(+5.2%)
Dec 2016
-$33.46 M(+11.6%)
-$7.94 M(-9.1%)
-$33.46 M(+1.5%)
Sep 2016
-
-$8.74 M(+3.9%)
-$32.97 M(+5.9%)
Jun 2016
-
-$8.41 M(+0.4%)
-$31.12 M(+2.1%)
Mar 2016
-
-$8.38 M(+12.5%)
-$30.49 M(+1.7%)
Dec 2015
-$29.99 M(+15.9%)
-$7.45 M(+8.1%)
-$29.99 M(+4.2%)
Sep 2015
-
-$6.89 M(-11.5%)
-$28.78 M(+1.0%)
Jun 2015
-
-$7.78 M(-1.3%)
-$28.50 M(+6.4%)
Mar 2015
-
-$7.88 M(+26.4%)
-$26.78 M(+3.5%)
Dec 2014
-$25.88 M(+23.9%)
-$6.23 M(-5.6%)
-$25.88 M(+1.9%)
Sep 2014
-
-$6.60 M(+8.8%)
-$25.39 M(+2.1%)
Jun 2014
-
-$6.07 M(-13.1%)
-$24.86 M(+2.2%)
Mar 2014
-
-$6.98 M(+21.6%)
-$24.33 M(+16.4%)
Dec 2013
-$20.89 M(+46.7%)
-$5.74 M(-5.5%)
-$20.89 M(+8.2%)
Sep 2013
-
-$6.07 M(+9.7%)
-$19.31 M(+11.3%)
Jun 2013
-
-$5.53 M(+56.0%)
-$17.35 M(+46.8%)
Mar 2013
-
-$3.55 M(-14.6%)
-$11.82 M(+42.9%)
Dec 2012
-$14.24 M(+6.0%)
-$4.16 M(+1.0%)
-$8.27 M(+101.0%)
Sep 2012
-
-$4.11 M
-$4.11 M
Dec 2011
-$13.43 M
-
-

FAQ

  • What is Fate Therapeutics annual net profit?
  • What is the all time high annual net income for Fate Therapeutics?
  • What is Fate Therapeutics annual net income year-on-year change?
  • What is Fate Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Fate Therapeutics?
  • What is Fate Therapeutics quarterly net income year-on-year change?
  • What is Fate Therapeutics TTM net profit?
  • What is the all time high TTM net income for Fate Therapeutics?
  • What is Fate Therapeutics TTM net income year-on-year change?

What is Fate Therapeutics annual net profit?

The current annual net income of FATE is -$160.93 M

What is the all time high annual net income for Fate Therapeutics?

Fate Therapeutics all-time high annual net profit is -$13.43 M

What is Fate Therapeutics annual net income year-on-year change?

Over the past year, FATE annual net profit has changed by +$120.79 M (+42.88%)

What is Fate Therapeutics quarterly net profit?

The current quarterly net income of FATE is -$47.68 M

What is the all time high quarterly net income for Fate Therapeutics?

Fate Therapeutics all-time high quarterly net profit is -$3.55 M

What is Fate Therapeutics quarterly net income year-on-year change?

Over the past year, FATE quarterly net profit has changed by -$2.51 M (-5.55%)

What is Fate Therapeutics TTM net profit?

The current TTM net income of FATE is -$178.23 M

What is the all time high TTM net income for Fate Therapeutics?

Fate Therapeutics all-time high TTM net profit is -$4.11 M

What is Fate Therapeutics TTM net income year-on-year change?

Over the past year, FATE TTM net profit has changed by -$5.06 M (-2.92%)